Consolidated Statement of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income (loss)		$ 1,675,000	$ 1,158,000	$ 1,056,000
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used for) operating activities:
Depreciation, amortization and accretion		1,707,000	1,644,000	1,608,000
(Gains) losses on retirement of long-term obligations	[1]	28,000	145,000	95,000
Amortization of deferred financing costs and other non-cash interest, net		17,000	13,000	6,000
Stock-based compensation expense		156,000	129,000	138,000
Asset write-down charges		34,000	21,000	74,000
Deferred income tax (benefit) provision		3,000	4,000	3,000
Other non-cash adjustments, net		5,000	21,000	5,000
Changes in assets and liabilities, excluding the effects of acquisitions:
Increase (decrease) in accrued interest		0	(17,000)	31,000
Increase (decrease) in accounts payable		(5,000)	15,000	(77,000)
Increase (decrease) in other liabilities		(281,000)	(118,000)	(65,000)
Decrease (increase) in receivables		(49,000)	(113,000)	166,000
Decrease (increase) in other assets		(412,000)	(113,000)	15,000
Net cash provided by (used for) operating activities		2,878,000	2,789,000	3,055,000
Cash flows from investing activities:
Capital expenditures		1,310,000	1,229,000	1,624,000
Payments for acquisitions, net of cash acquired		35,000	111,000	107,000
Other investing activities, net		(7,000)	8,000	(10,000)
Net cash provided by (used for) investing activities		(1,352,000)	(1,332,000)	(1,741,000)
Cash flows from financing activities:
Proceeds from issuance of long-term debt		748,000	3,985,000	3,733,000
Principal payments on debt and other long-term obligations		74,000	1,076,000	105,000
Purchases and redemptions of long-term debt		1,274,000	2,089,000	2,490,000
Borrowings under revolving credit facility		3,495,000	1,245,000	2,430,000
Payments under revolving credit facility		2,855,000	870,000	2,665,000
Net issuances (repayments) under commercial paper program		976,000	(20,000)	130,000
Payments for financing costs		14,000	42,000	38,000
Purchases of common stock		65,000	70,000	76,000
Dividends/distributions paid on common stock		2,602,000	2,373,000	2,105,000
Dividends/distributions paid on preferred stock		0	0	85,000
Net cash provided by (used for) financing activities		(1,665,000)	(1,310,000)	(1,271,000)
Net increase (decrease) in cash, cash equivalents, and restricted cash from continuing operations		(139,000)	147,000	43,000
Net Cash Provided by (Used in) Discontinued Operations		0	(62,000)	0
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect		0	0	0
Cash Provided by (Used in) Operating Activities, Discontinued Operations		0	(62,000)	0
Cash, Cash Equivalents and Restricted Cash - Beginning of Period		466,000	381,000	338,000
Cash, Cash Equivalents and Restricted Cash - End of Period		$ 327,000	$ 466,000	$ 381,000

[1] Inclusive of the write-off of the respective deferred financing costs.